NORDIC9: A randomized phase II trial comparing first-line palliative full-dose monotherapy (S-1) with reduced dose-combination therapy (SOx) in older and frail patients with metastatic colorectal cancer (mCRC)

S. B. Winther; H. Skuladottir; E. Hofsli; C-H. Shah; M. K. Yilmaz; P. J. Osterlund; A. Berglund; B. Glimelius; C. Qvortrup; H. Sorbye; P. Pfeiffer

doi:10.1093/annonc/mdy281.003

NORDIC9: A randomized phase II trial comparing first-line palliative full-dose monotherapy (S-1) with reduced dose-combination therapy (SOx) in older and frail patients with metastatic colorectal cancer (mCRC)

S. B. Winther, H. Skuladottir, E. Hofsli, C-H. Shah, M. K. Yilmaz, P. J. Osterlund, A. Berglund, B. Glimelius, C. Qvortrup, H. Sorbye, P. Pfeiffer

KI, OUH, Forskningsenhed for Onkologi (Odense)

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	Annals of Oncology
Vol/bind	29
Udgave nummer	Suppl. 8
Sider (fra-til)	viii151
Antal sider	1
ISSN	0923-7534
DOI	https://doi.org/10.1093/annonc/mdy281.003
Status	Udgivet - 1. okt. 2018
Begivenhed	43rd ESMO Congress - Munich, Tyskland Varighed: 19. okt. 2018 → 23. okt. 2018

Konference

Konference	43rd ESMO Congress
Land/Område	Tyskland
By	Munich
Periode	19/10/2018 → 23/10/2018

Bibliografisk note

43rd ESMO Congress (ESMO), Munich, GERMANY, OCT 19-23, 2018

Dokumenter og links

10.1093/annonc/mdy281.003Licens: CC BY-NC-ND

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

Winther, S. B., Skuladottir, H., Hofsli, E., Shah, C.-H., Yilmaz, M. K., Osterlund, P. J., Berglund, A., Glimelius, B., Qvortrup, C., Sorbye, H., & Pfeiffer, P. (2018). NORDIC9: A randomized phase II trial comparing first-line palliative full-dose monotherapy (S-1) with reduced dose-combination therapy (SOx) in older and frail patients with metastatic colorectal cancer (mCRC). Annals of Oncology, 29(Suppl. 8), viii151. https://doi.org/10.1093/annonc/mdy281.003

@article{6df8330d7f6b4854bbb0f8e816151f71,

title = "NORDIC9: A randomized phase II trial comparing first-line palliative full-dose monotherapy (S-1) with reduced dose-combination therapy (SOx) in older and frail patients with metastatic colorectal cancer (mCRC)",

author = "Winther, \{S. B.\} and H. Skuladottir and E. Hofsli and C-H. Shah and Yilmaz, \{M. K.\} and Osterlund, \{P. J.\} and A. Berglund and B. Glimelius and C. Qvortrup and H. Sorbye and P. Pfeiffer",

note = "43rd ESMO Congress (ESMO), Munich, GERMANY, OCT 19-23, 2018; 43rd ESMO Congress, ESMO 2018 ; Conference date: 19-10-2018 Through 23-10-2018",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy281.003",

language = "English",

volume = "29",

pages = "viii151",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier",

number = "Suppl. 8",

}

Winther, SB, Skuladottir, H, Hofsli, E, Shah, C-H, Yilmaz, MK, Osterlund, PJ, Berglund, A, Glimelius, B, Qvortrup, C, Sorbye, H & Pfeiffer, P 2018, 'NORDIC9: A randomized phase II trial comparing first-line palliative full-dose monotherapy (S-1) with reduced dose-combination therapy (SOx) in older and frail patients with metastatic colorectal cancer (mCRC)', Annals of Oncology, bind 29, nr. Suppl. 8, s. viii151. https://doi.org/10.1093/annonc/mdy281.003

NORDIC9: A randomized phase II trial comparing first-line palliative full-dose monotherapy (S-1) with reduced dose-combination therapy (SOx) in older and frail patients with metastatic colorectal cancer (mCRC). / Winther, S. B.; Skuladottir, H.; Hofsli, E. et al.
I: Annals of Oncology, Bind 29, Nr. Suppl. 8, 01.10.2018, s. viii151.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - NORDIC9: A randomized phase II trial comparing first-line palliative full-dose monotherapy (S-1) with reduced dose-combination therapy (SOx) in older and frail patients with metastatic colorectal cancer (mCRC)

AU - Winther, S. B.

AU - Skuladottir, H.

AU - Hofsli, E.

AU - Shah, C-H.

AU - Yilmaz, M. K.

AU - Osterlund, P. J.

AU - Berglund, A.

AU - Glimelius, B.

AU - Qvortrup, C.

AU - Sorbye, H.

AU - Pfeiffer, P.

N1 - 43rd ESMO Congress (ESMO), Munich, GERMANY, OCT 19-23, 2018

PY - 2018/10/1

Y1 - 2018/10/1

U2 - 10.1093/annonc/mdy281.003

DO - 10.1093/annonc/mdy281.003

M3 - Conference abstract in journal

SN - 0923-7534

VL - 29

SP - viii151

JO - Annals of Oncology

JF - Annals of Oncology

IS - Suppl. 8

T2 - 43rd ESMO Congress

Y2 - 19 October 2018 through 23 October 2018

ER -

Winther SB, Skuladottir H, Hofsli E, Shah CH, Yilmaz MK, Osterlund PJ et al. NORDIC9: A randomized phase II trial comparing first-line palliative full-dose monotherapy (S-1) with reduced dose-combination therapy (SOx) in older and frail patients with metastatic colorectal cancer (mCRC). Annals of Oncology. 2018 okt. 1;29(Suppl. 8):viii151. doi: 10.1093/annonc/mdy281.003